JMP Securities Reiterates Market Perform on Avanos Medical
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Daniel Stauder has reiterated a 'Market Perform' rating on Avanos Medical (NYSE:AVNS), indicating a neutral outlook on the company's stock.

May 07, 2024 | 3:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JMP Securities analyst Daniel Stauder reiterates a 'Market Perform' rating on Avanos Medical, suggesting a neutral short-term impact on the stock.
The reiteration of a 'Market Perform' rating by a JMP Securities analyst suggests that there are no significant short-term catalysts expected to drive Avanos Medical's stock price significantly higher or lower. This rating indicates a neutral view on the stock, implying that the analyst does not foresee substantial price movement in the near term based on current information.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90